Argent Capital Management Llc decreased Vonage Holdings Corporation (VG) stake by 11.1% reported in 2019Q1 SEC filing. Argent Capital Management Llc sold 37,500 shares as Vonage Holdings Corporation (VG)’s stock rose 17.99%. The Argent Capital Management Llc holds 300,225 shares with $3.01M value, down from 337,725 last quarter. Vonage Holdings Corporation now has $2.87B valuation. It closed at $11.85 lastly. It is down 2.68% since June 9, 2018 and is uptrending. It has underperformed by 1.75% the S&P500. Some Historical VG News: 16/04/2018 – MyEyeDr Selects Vonage as Its Business Commun Partner; 08/05/2018 – Vonage Holdings 1Q EPS 10c; 14/05/2018 – Vonage Presenting at JPMorgan Conference Tomorrow; 20/03/2018 – Vonage Launches New Comprehensive Channel Program to Accelerate Adoption of Business Cloud Communications in the Mid-Market and Enterprise Segments; 08/05/2018 – VONAGE HOLDINGS CORP – QTRLY DILUTED SHR $0.10; 08/05/2018 – VONAGE 1Q REV. $254M, EST. $251.7M; 08/05/2018 – VONAGE 1Q ADJ EPS 13C, EST. 7.0C; 23/04/2018 – DJ Vonage Holdings Corp, Inst Holders, 1Q 2018 (VG); 25/05/2018 – Vonage Presenting at Conference May 30; 08/05/2018 – Vonage Holdings 1Q Rev $253.6M
Farallon Capital Management Llc increased Chemocentryx Inc (CCXI) stake by 3.45% reported in 2019Q1 SEC filing. Farallon Capital Management Llc acquired 50,000 shares as Chemocentryx Inc (CCXI)’s stock rose 15.42%. The Farallon Capital Management Llc holds 1.50M shares with $20.84 million value, up from 1.45 million last quarter. Chemocentryx Inc now has $502.70 million valuation. The stock decreased 0.57% or $0.05 during the last trading session, reaching $8.66. About 411,939 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 11.16% since June 9, 2018 and is uptrending. It has outperformed by 6.73% the S&P500. Some Historical CCXI News: 09/03/2018 ChemoCentryx 4Q EPS 80c; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – CCXI TO BEGIN AVACOPAN CLINICAL STUDIES IN HS BY ’18 END; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx
Since January 7, 2019, it had 0 insider buys, and 5 insider sales for $1.38 million activity. KANAYA SUSAN M sold 37,893 shares worth $457,747. Schall Thomas J. sold $447,092 worth of stock. Shares for $158,790 were sold by Cappel Markus J..
Investors sentiment increased to 1.44 in Q1 2019. Its up 0.51, from 0.93 in 2018Q4. It improved, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. Element Capital Mngmt Limited Co invested in 11,906 shares. Public Employees Retirement Sys Of Ohio invested 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Bnp Paribas Arbitrage stated it has 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Sio Cap Management Ltd Liability Company holds 1.99% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 530,175 shares. Jpmorgan Chase And holds 5,481 shares. Sei Invests Co invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Invesco Limited owns 148,988 shares. Moreover, Vanguard Grp has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 1.29M shares. State Street invested in 0% or 457,546 shares. Deutsche National Bank & Trust Ag, Germany-based fund reported 115,826 shares. The North Carolina-based National Bank & Trust Of America De has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Blackrock Incorporated accumulated 2.65 million shares. Citigroup stated it has 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Swiss National Bank & Trust invested in 0% or 41,500 shares. Raymond James Associates invested in 13,874 shares or 0% of the stock.
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Seekingalpha.com which released: “InflaRx downdraft engulfs ChemoCentryx, down 28% premarket – ChemoCentryx, Inc. (NASDAQ:CCXI) – Seeking Alpha” on June 05, 2019, also Nasdaq.com with their article: “ChemoCentryx (CCXI) Moves to Buy: Rationale Behind the Upgrade – Nasdaq” published on May 20, 2019, Seekingalpha.com published: “SCYNEXIS and ReWalk Robotics among healthcare gainers; Stellar Biotechnologies and ChemoCentryx among losers – Seeking Alpha” on June 05, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Benzinga.com and their article: “The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering – Benzinga” published on June 06, 2019 as well as Benzinga.com‘s news article titled: “66 Biggest Movers From Yesterday – Benzinga” with publication date: June 06, 2019.
Farallon Capital Management Llc decreased Cigna Corp New stake by 110,000 shares to 945,000 valued at $151.98M in 2019Q1. It also reduced Translate Bio Inc stake by 400,000 shares and now owns 100,000 shares. General Dynamics Corp (NYSE:GD) was reduced too.
Among 4 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ChemoCentryx had 6 analyst reports since February 11, 2019 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, March 27 by FBR Capital. On Thursday, February 14 the stock rating was initiated by Leerink Swann with “Buy”. H.C. Wainwright maintained ChemoCentryx, Inc. (NASDAQ:CCXI) on Tuesday, March 12 with “Buy” rating.
Investors sentiment decreased to 0.99 in Q1 2019. Its down 0.20, from 1.19 in 2018Q4. It is negative, as 38 investors sold VG shares while 71 reduced holdings. 41 funds opened positions while 67 raised stakes. 193.50 million shares or 1.06% less from 195.58 million shares in 2018Q4 were reported. 5,139 are owned by Meeder Asset Mgmt. Stephens Ar invested in 64,288 shares. Stratos Wealth Prtn Limited invested in 0.01% or 16,268 shares. Parallax Volatility Advisers Lp holds 55,790 shares. Bluemountain Capital Mgmt Ltd Company stated it has 0% in Vonage Holdings Corp. (NYSE:VG). Los Angeles Mngmt Equity Rech Inc, a California-based fund reported 189,525 shares. Canada Pension Plan Investment Board holds 0.01% of its portfolio in Vonage Holdings Corp. (NYSE:VG) for 360,356 shares. Numerixs Invest Techs, British Columbia – Canada-based fund reported 41,834 shares. Geode Cap Mgmt Limited Company has invested 0.01% of its portfolio in Vonage Holdings Corp. (NYSE:VG). Us Bank & Trust De has 0% invested in Vonage Holdings Corp. (NYSE:VG). Gemmer Asset Management Ltd Limited Liability Company owns 0% invested in Vonage Holdings Corp. (NYSE:VG) for 338 shares. Mutual Of America Capital Management Ltd reported 0% in Vonage Holdings Corp. (NYSE:VG). Prudential Fincl accumulated 504,993 shares or 0.01% of the stock. 46,306 are owned by Wilbanks Smith And Thomas Asset Ltd Liability Corporation. 185,000 were reported by Employees Retirement Of Texas.
Since December 17, 2018, it had 0 insider buys, and 2 sales for $5.94 million activity. Citron Jeffrey A sold 250,000 shares worth $2.27 million.
Argent Capital Management Llc increased Marvell Technology Group Ltd (NASDAQ:MRVL) stake by 68,612 shares to 5.03M valued at $100.06M in 2019Q1. It also upped Universal Logistics Holdings (NASDAQ:UACL) stake by 26,999 shares and now owns 91,774 shares. Diodes Incorporated (NASDAQ:DIOD) was raised too.
More notable recent Vonage Holdings Corp. (NYSE:VG) news were published by: Benzinga.com which released: “Uber’s First Day On Wall Street – Benzinga” on May 10, 2019, also Benzinga.com with their article: “25 Stocks Moving In Thursday’s Pre-Market Session – Benzinga” published on May 30, 2019, Prnewswire.com published: “Vonage to Present at the Baird 2019 Global Consumer, Technology & Services Conference – PRNewswire” on June 03, 2019. More interesting news about Vonage Holdings Corp. (NYSE:VG) were released by: Prnewswire.com and their article: “Omar Javaid Named President of Vonage’s API Platform Group – PRNewswire” published on May 13, 2019 as well as Businesswire.com‘s news article titled: “Vonage Wins 2019 INTERNET TELEPHONY Product of the Year Awards – Business Wire” with publication date: May 20, 2019.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.